Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-23-005908

Chief Financial Officer sold 924 shares at $11.78 ($10,884)

  • Chief Financial Officer acquired 2,886 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
van Houte Hans Chief Financial Officer 2023-01-30 Option exercise +2,886 77,689 D: show line 1 in the form
van Houte Hans Chief Financial Officer 2023-01-30 Sale −924 $11.78 $10,884 76,765 D: show line 2 in the form
Open-market sales · 924 sh · avg $11.78 · $10,884

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
van Houte Hans Chief Financial Officer 2023-01-30 Option exercise · Restricted Stock Units −2,886 34,633 D: show line 3 in the form
Loading xslF345X03/doc4.xml…